newsfilter
← Latest News
ACCESS Newswire·

Hemogenyx Pharmaceuticals PLC Announces U.S. Approval of Monoclonal Antibody Patent

LONDON, UK / ACCESSWIRE / September 2, 2021 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, is pleased to announce that a further patent application entitled MONOCLONAL A